These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1320207)

  • 1. O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition.
    Pertz H; Eich E
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):394-401. PubMed ID: 1320207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
    Pertz HH; Brown AM; Gager TL; Kaumann AJ
    J Pharm Pharmacol; 1999 Mar; 51(3):319-30. PubMed ID: 10344634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
    Pertz H
    Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML; Parli CJ; Fuller RW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.
    Pertz H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):558-65. PubMed ID: 8133899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.
    Krisch I; Bole-Vunduk B; Pepelnak M; Lavric B; Ocvirk A; Budihna MV; Sket D
    J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alpha 1-adrenoceptors and 5-HT2 receptors in serotonin-induced contraction of rat prostate: autoradiographical and functional studies.
    Killam AL; Watts SW; Cohen ML
    Eur J Pharmacol; 1995 Jan; 273(1-2):7-14. PubMed ID: 7737320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
    Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
    Kaumann AJ; Frenken M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.
    Kaumann AJ; Frenken M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery.
    Uma S; Tuncer M; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):248-55. PubMed ID: 3675084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity study of some newly synthesized ergoline derivatives on 5-HT2 receptors and alpha-adrenoceptors in rabbit isolated aorta.
    Krisch I; Budihna MV; Rucman R
    Pharmacology; 1992; 45(4):195-208. PubMed ID: 1332086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of alpha 1-adrenoceptor antagonism of ketanserin on the nature of its 5-HT2 receptor antagonism.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):955-61. PubMed ID: 7736654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.